Intellectual Property
AVYCAZ (Ceftazidime and Avibactam) Patent Litigation
Pending actions
2
Historical total
2
Resolved / remanded
0
Newly Centralized. Consolidated within the last 18 months. Of 2 lawsuits ever part of this litigation, 2 remain active.
About this litigation
AVYCAZ (Ceftazidime and Avibactam) Patent Litigation is a federal multidistrict litigation classified by the Judicial Panel on Multidistrict Litigation as a Intellectual Property docket. It was centralized on February 6, 2025 before Zahid N. Quraishi, U.S. District Judge, in the D. New Jersey.
As of the August 3, 2026 JPML report, 2 individual lawsuits are pending in this MDL. Cases coordinated in an MDL keep their separate identity — they are managed together only for pretrial proceedings. Learn how MDLs work.
Related Intellectual Property MDLs
View categoryRare Breed Triggers Patent Litigation
59
pending actions
MDL 3176
E.D. Texas
OpenAI, Inc., Copyright Infringement Litigation
19
pending actions
MDL 3143
S.D. New York
Denosumab Patent Litigation
8
pending actions
MDL 3138
D. New Jersey
Neo Wireless, LLC, Patent Litigation
7
pending actions
MDL 3034
E.D. Michigan